# A Study of CS23546 in Subjects With Advanced Tumors

> **NCT06245122** · PHASE1 · RECRUITING · sponsor: **Chipscreen Biosciences, Ltd.** · enrollment: 156 (estimated)

## Conditions studied

- Advanced Tumors

## Interventions

- **DRUG:** CS23546

## Key facts

- **NCT ID:** NCT06245122
- **Lead sponsor:** Chipscreen Biosciences, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-27
- **Primary completion:** 2027-02-28
- **Final completion:** 2027-05-31
- **Target enrollment:** 156 (ESTIMATED)
- **Last updated:** 2026-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06245122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06245122, "A Study of CS23546 in Subjects With Advanced Tumors". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06245122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*